<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sonu</submitter><funding>King Khalid University Deanship of Scientific Research</funding><funding>King Khalid University</funding><pagination>e40300</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11617876</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(22)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The present study is aimed to investigate the anti-inflammatory activities of thirteen substituted-isoxazole derivatives (5a-5m). Isoxazole is a key pharmacophore in medicinal chemistry, known for its broad range of pharmacological activities.This study explores the synthesis and anti-inflammatory potential of thirteen substituted-isoxazole derivatives (5a-5m), with &lt;b>5c, 5d, 5e,&lt;/b> and &lt;b>5g&lt;/b> being novel compounds.&lt;h4>Objectives&lt;/h4>The primary objectives were to synthesize some novel substituted isoxazole derivatives, evaluate their interaction with cyclooxygenase (COX-1/2) enzymes through computational methods, and assess their anti-inflammatory effectiveness in laboratory animals.&lt;h4>Methods&lt;/h4>Substituted chalcones (0.01 mol) (2a-2m), sodium ethoxide (0.01 mol), and hydroxylamine hydrochloride (0.01 mol) were dissolved in absolute ethanol (15 ml), and then the mixture was refluxed for 6 h in an oil bath and monitored by TLC (ethyl acetate:hexane 7:3 v/v as eluent; a UV lamp was used to visualize the plates). After the completion of the reaction, as per TLC, the contents of the reaction mixture were poured into ice-cold water (50 ml). The obtained precipitates were filtered, washed two times, dried for 2 h at room temperature, and then recrystallized with ethenol. The structures of these compounds were confirmed via Fourier transform infrared spectroscopy (FT-IR), proton nuclear magnetic resonance (&lt;sup>1&lt;/sup>H NMR) spectroscopy, carbon-13 nuclear magnetic resonance (&lt;sup>13&lt;/sup>C NMR) spectroscopy, and mass spectrometry. Anti-inflammatory activity was evaluated using the carrageenan-induced rat paw edema method.&lt;h4>Results&lt;/h4>The results indicated that three compounds (&lt;b>5b, 5c,&lt;/b> and &lt;b>5d&lt;/b>) demonstrated significant &lt;i>in vivo&lt;/i> anti-inflammatory potential (% edema inhibition 75.68, 74.48, &amp; 71.86 in 2 h and 76.71, 75.56, &amp; 72.32 in 3 h) with modest effectiveness (0.83, 0.81 &amp; 0.71), low toxicity, and minimal adverse effects. The molecular docking analyses further elucidated the interaction with the active site COX-2 enzyme (PDB ID: 4COX) using Autodock Vina. The compounds &lt;b>5b, 5c,&lt;/b> and &lt;b>5d&lt;/b> -8.7, -8.5, and -8.4 indicate good binding affinity (kcal/mol) and H-bond interaction with residues such as Cys41, Ala151, and Arg120 for COX-2, which also carried out RMSD values of 2.174, 41.13, and 22.25, which are decisive for the reported anti-inflammatory activity of diverse compounds.&lt;h4>Conclusions&lt;/h4>The findings indicate that isoxazole derivatives have modest antiinflammatory potential, with compounds (&lt;b>5b, 5c,&lt;/b> and &lt;b>5d&lt;/b>) acting as lead molecules to be studied further for pain relief with fewer adverse effects.</pubmed_abstract><journal>Heliyon</journal><pubmed_title>Synthesis, characterization, molecular docking and pharmacological evaluation of isoxazole derivatives as potent anti-inflammatory agents.</pubmed_title><pmcid>PMC11617876</pmcid><funding_grant_id>RGP2/580/45</funding_grant_id><pubmed_authors>Singh H</pubmed_authors><pubmed_authors>Mishra AK</pubmed_authors><pubmed_authors>Sonu</pubmed_authors><pubmed_authors>Parveen BR</pubmed_authors><pubmed_authors>Singh M</pubmed_authors><pubmed_authors>Yt K</pubmed_authors><pubmed_authors>Kumar A</pubmed_authors><pubmed_authors>Gautam GK</pubmed_authors></additional><is_claimable>false</is_claimable><name>Synthesis, characterization, molecular docking and pharmacological evaluation of isoxazole derivatives as potent anti-inflammatory agents.</name><description>&lt;h4>Background&lt;/h4>The present study is aimed to investigate the anti-inflammatory activities of thirteen substituted-isoxazole derivatives (5a-5m). Isoxazole is a key pharmacophore in medicinal chemistry, known for its broad range of pharmacological activities.This study explores the synthesis and anti-inflammatory potential of thirteen substituted-isoxazole derivatives (5a-5m), with &lt;b>5c, 5d, 5e,&lt;/b> and &lt;b>5g&lt;/b> being novel compounds.&lt;h4>Objectives&lt;/h4>The primary objectives were to synthesize some novel substituted isoxazole derivatives, evaluate their interaction with cyclooxygenase (COX-1/2) enzymes through computational methods, and assess their anti-inflammatory effectiveness in laboratory animals.&lt;h4>Methods&lt;/h4>Substituted chalcones (0.01 mol) (2a-2m), sodium ethoxide (0.01 mol), and hydroxylamine hydrochloride (0.01 mol) were dissolved in absolute ethanol (15 ml), and then the mixture was refluxed for 6 h in an oil bath and monitored by TLC (ethyl acetate:hexane 7:3 v/v as eluent; a UV lamp was used to visualize the plates). After the completion of the reaction, as per TLC, the contents of the reaction mixture were poured into ice-cold water (50 ml). The obtained precipitates were filtered, washed two times, dried for 2 h at room temperature, and then recrystallized with ethenol. The structures of these compounds were confirmed via Fourier transform infrared spectroscopy (FT-IR), proton nuclear magnetic resonance (&lt;sup>1&lt;/sup>H NMR) spectroscopy, carbon-13 nuclear magnetic resonance (&lt;sup>13&lt;/sup>C NMR) spectroscopy, and mass spectrometry. Anti-inflammatory activity was evaluated using the carrageenan-induced rat paw edema method.&lt;h4>Results&lt;/h4>The results indicated that three compounds (&lt;b>5b, 5c,&lt;/b> and &lt;b>5d&lt;/b>) demonstrated significant &lt;i>in vivo&lt;/i> anti-inflammatory potential (% edema inhibition 75.68, 74.48, &amp; 71.86 in 2 h and 76.71, 75.56, &amp; 72.32 in 3 h) with modest effectiveness (0.83, 0.81 &amp; 0.71), low toxicity, and minimal adverse effects. The molecular docking analyses further elucidated the interaction with the active site COX-2 enzyme (PDB ID: 4COX) using Autodock Vina. The compounds &lt;b>5b, 5c,&lt;/b> and &lt;b>5d&lt;/b> -8.7, -8.5, and -8.4 indicate good binding affinity (kcal/mol) and H-bond interaction with residues such as Cys41, Ala151, and Arg120 for COX-2, which also carried out RMSD values of 2.174, 41.13, and 22.25, which are decisive for the reported anti-inflammatory activity of diverse compounds.&lt;h4>Conclusions&lt;/h4>The findings indicate that isoxazole derivatives have modest antiinflammatory potential, with compounds (&lt;b>5b, 5c,&lt;/b> and &lt;b>5d&lt;/b>) acting as lead molecules to be studied further for pain relief with fewer adverse effects.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Nov</publication><modification>2026-06-02T03:37:58.601Z</modification><creation>2025-04-04T01:57:42.472Z</creation></dates><accession>S-EPMC11617876</accession><cross_references><pubmed>39641075</pubmed><doi>10.1016/j.heliyon.2024.e40300</doi></cross_references></HashMap>